DAN MULTI-YEAR TREND
Danapha Pharmaceutical joint stock company — UPCOM
| Metric / CHỈ TIÊU | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | Change / BIẾN ĐỘNG |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets Tổng tài sản | 2,180,999,157 | 1,596,130,654 | 1,294,614,992 | 1,074,248,114 | — | — | — | — | — | — | — | — |
| Owner's Equity Vốn chủ sở hữu | 850,676,946 | 764,927,393 | 710,085,934 | 649,177,895 | — | — | — | — | — | — | — | — |
| Revenue Doanh thu | 650,620,487 | 572,176,321 | 598,506,930 | 559,812,683 | — | — | — | — | — | — | — | — |
| Net Profit After Tax Lợi nhuận sau thuế | 85,749,553 | 69,998,059 | 76,564,639 | 49,313,408 | — | — | — | — | — | — | — | — |
| ROE (%) Tỷ suất lợi nhuận trên VCSH | 10.08% | 9.15% | 10.78% | 7.60% | — | — | — | — | — | — | — | — |
| ROA (%) Tỷ suất lợi nhuận trên tài sản | 3.93% | 4.39% | 5.91% | 4.59% | — | — | — | — | — | — | — | — |
| Gross Margin (%) Biên lợi nhuận gộp | 54.70% | 51.25% | 43.74% | 48.37% | — | — | — | — | — | — | — | — |
| Net Margin (%) Biên lợi nhuận ròng | 13.18% | 12.23% | 12.79% | 8.81% | — | — | — | — | — | — | — | — |
| Debt/Equity Nợ/Vốn chủ sở hữu | 1.56% | 1.09% | 0.82% | 0.65% | — | — | — | — | — | — | — | — |